treatment drugs have been determined “more effective” than the others and will be the only ones used on patients going forward, the World Health Organisation has announced.
During trials, REGN-EB3 and mAb114 were determined to be more effective in treating Ebola than the other two, and will be the only two used going forward, the National Institute of Allergy and Infectious Diseases announced in a statement.
The new experimental treatments are both cocktails of monoclonal antibodies that are infused intravenously into the blood, the New York Times reported. Mr Muyembe, 77, pioneered the use of survivors’ blood serum — which contains antibodies — in order to save patients. The two new treatments descend in part from his original research, the New York Times said.Ebola is a virus that is transmitted through direct contact with bodily fluids of someone infected with the virus or who has died from it, or through blood, body fluids or tissues of infected fruit bats or primates.
Good news.
ME approves two highly effective Ebola drugs for immediate use